Application of hollow manganese dioxide in cancer diagnosis and treatment
Journal of Biomaterials Applications · 2025
DOI: 10.1177/08853282251408712 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Xinyu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, China. Hauptthemen laut MEDLINE: Manganese Compounds, Oxides, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Malignant tumors pose a serious threat to human health. They are characterized by high incidence and indistinct early symptoms. Advances in medical technology have revealed the limitations of conventional therapies. Consequently, precision, minimally invasive, and integrated diagnosis and treatment have become key objectives in modern oncology. Nanomedicine shows considerable potential for precision therapy. However, novel nanocarriers that combine high efficiency, precise targeting, controllable drug release, and excellent biocompatibility are still urgently needed. Hollow manganese dioxide is a promising inorganic nanomaterial. It exhibits high drug loading capacity, responsiveness to the tumor microenvironment, and favorable biocompatibility. These properties make it an excellent drug carrier for cancer therapy. Synthetic methods for constructing MnO 2 -based multifunctional nanoplatforms continue to advance. This review highlights promising applications of hollow MnO 2 in drug delivery, bioimaging, and biosensing. Finally, we summarize the associated challenges and future prospects in anticancer applications, aiming to provide meaningful guidance for further research.p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, China.
ORCID-Profile: Xuejiao Ma, Bo Lu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Chang, J., Ma, X., & Lu, B. (2025). Application of hollow manganese dioxide in cancer diagnosis and treatment. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251408712
Vancouver
Wang X, Chang J, Ma X, Lu B. Application of hollow manganese dioxide in cancer diagnosis and treatment. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251408712
BibTeX
@article{Wang2025,
author = {Wang, Xinyu and Chang, Jingrui and Ma, Xuejiao and Lu, Bo},
title = {Application of hollow manganese dioxide in cancer diagnosis and treatment},
journal = {Journal of Biomaterials Applications},
year = {2025},
doi = {10.1177/08853282251408712}
}
EUVIMED